Endpoint Health Enters into Global Collaboration and Licensing Agreement with Grifols

PALO ALTO, Calif.--(BUSINESS WIRE)--Endpoint Health, Inc., a precision-firstTM therapeutics company dedicated to addressing urgent needs in immune-driven critical and chronic illnesses, today announced that the company has entered into a global collaboration and licensing agreement with Grifols, a leading global producer of plasma-derived medicines, under which Endpoint Health will receive...

Click to view original post